WELCOME

Improving patient outcomes and the treatment of cancer in North Dakota and South Dakota

UPCOMING EVENTS

REGISTER

ONCOLOGY NEWS

FDA Approves Fruquintinib in Refractory Metastatic Colorectal Cancer

MORE ONCOLOGY NEWS

MEMBER BENEFIT

JOIN THE CONVERSATION